SecBot SecBot
8-K ·Filed Mar 19, 2026

GBCS

SELECTIS HEALTH, INC.
NEUTRAL
Impact 3/10
Horizonweeks Processed7mo ago SEC0001493152-26-011364
8-K context-dependent: Items 5.02
Actionable Insight • Neutral

Monitor for potential strategic shifts given the addition of a financial services veteran to the board, though no immediate operational changes are indicated. The appointment suggests board strengthening rather than a response to crisis.

DirectionNeutral
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
GBCS ▼ -19.26% at T+60d
NEUTRAL call -19.26% · α vs SPY -33.60% · entry $4.05 → $3.27
Entry = T+0 close
Mar 19, 2026
via day close
T+1d
0.00%
call 0.00% · α +1.74%
$4.05
settled 7mo ago
T+5d
+8.40%
call +8.40% · α +10.61%
$4.39
settled 7mo ago
T+20d
+8.64%
call +8.64% · α +1.02%
$4.40
settled 6mo ago
T+60d
-19.26%
call -19.26% · α -33.60%
$3.27
settled 4mo ago

Price Chart

Loading chart...

Executive Summary

Selectis Health, Inc. appointed Richard Huebner, age 68, to its Board of Directors effective March 12, 2026. Huebner brings extensive financial services experience, including roles at GVC Capital LLC, Fiserv, and Hanifen Imhoff. He will receive an annual stipend of $30,000 under the company's Outside Directors Compensation Plan.

Key Facts

  • Richard Huebner appointed to Board of Directors effective March 12, 2026
  • Huebner, 68, has served as senior managing partner and investment banker at GVC Capital LLC since 2001
  • Prior experience includes Executive Vice President at Fiserv Correspondent Services (1984-2000) and various senior roles at Hanifen Imhoff
  • Huebner holds a JD from University of Nebraska and BA from Hastings College
  • Annual compensation of $30,000 payable quarterly in cash under the Outside Directors Compensation Plan

Financial Impact

Minimal - $30,000 annual director compensation expense

operating expensesdirector compensation

Risk Factors

  • Limited immediate impact as appointment is of a non-executive director
  • No indication of strategic direction change or operational improvements

Market Snapshot

Exchange
OTC

Investment Themes

Real Estate

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001493152-26-011364
Document: 0001493152-26-011364-index-headers.html0001493152-26-011364
Document: 0001493152-26-011364-index.html0001493152-26-011364
Document: 0001493152-26-011364.txt0001493152-26-011364
6 reports for GBCS
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for GBCS — sortable, filterable
TypeNow
Oct 9, 2026
18d ago
15-12G
BEARISH ★ 7/10
—awaiting T+20——
Oct 9, 2026
18d ago
8-K
BULLISH ★ 8/10
—awaiting T+20——
Sep 8, 2026
6w ago
8-K
BULLISH ★ 7/10
$5.74 $5.73▼ −0.17%▼ −2.37%—
May 20, 2026
22w ago
8-K
BEARISH ★ 6/10
$3.31 $3.25▲ +1.81%▲ +2.55%—
May 7, 2026
24w ago
8-K
MIXED ★ 5/10
$3.14 $3.10▼ −1.27%▼ −1.30%—
Mar 19, 2026
31w ago
8-K
NEUTRAL ★ 3/10
$4.05 $4.40▲ +8.64%▲ +1.02%—
Showing 6 of 6

US Market Status

Market Closed — Opens Wed (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Mar 19, 2026